Oregon
Oregon
-
Providence notifies patients of recommended testing
-
See stories of hope in annual report to our communities
In 2023, Providence in Oregon did so much to make sure that essential resources – such as health care, food and shelter – were more readily available to the people of our state.
-
Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
-
K-9 team brings smiles and safety to Providence Portland
Walk in the shoes of security officer Patricia Varela and her K-9 partner Nix, and experience their important work to keep everyone safe at Providence Portland Medical Center.
-
The evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
- GET THE APP ›
-
Welcome back
This morning, six Providence hospitals in Oregon welcomed our nurses back as we began working together again.
-
3 things to know about getting care during the ONA strikes
Here's what to know about getting care at Providence hospitals during the Oregon Nurses Association strike.
-
Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
- FIND A DOCTOR ›
-
Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
-
Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
-
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
-
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
- LEARN MORE
-
Providence Oregon hospitals earn national recognition for environmental stewardship work
Practice Greenhealth recognizes Providence’s commitment to environmental stewardship, names Providence a ‘System of Change’
-
Celebrating World Immunology Day
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
- FIND A CLINIC ›
-
Jennifer Burrows, RN, to lead Providence Oregon
Jennifer Burrows, RN, has been chosen to serve as the chief executive of Providence Oregon.
-
New vaccine being studied for HPV+ head and neck cancer
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
-
Celebrating our oncology social workers
In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.
-
Talking to an expert: The crucial role of nutrition in cancer care
In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.
-
How promoting apoptosis in new study may help people with cancer
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
-
Epic e-prescribing returns to normal operations following cyber-attack
Please revert to normal e-prescribing workflows and stop using paper prescriptions.
-
Loading More...